InMed Pharmaceuticals Inc. (INM) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $15.58M | +31.8% |
| 2024 | $11.82M | -16.2% |
| 2023 | $14.11M | +10.3% |
| 2022 | $12.79M | +30.7% |
| 2021 | $9.78M | +25.4% |
| 2020 | $7.80M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $15.58M | +31.8% |
| 2024 | $11.82M | -16.2% |
| 2023 | $14.11M | +10.3% |
| 2022 | $12.79M | +30.7% |
| 2021 | $9.78M | +25.4% |
| 2020 | $7.80M | — |